focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCavendish Fin Regulatory News (CAV)

Share Price Information for Cavendish Fin (CAV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.50
Bid: 11.00
Ask: 12.00
Change: 0.00 (0.00%)
Spread: 1.00 (9.091%)
Open: 11.50
High: 11.50
Low: 11.50
Prev. Close: 11.50
CAV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

19 Dec 2023 07:00

RNS Number : 2175X
Cavendish Financial PLC
19 December 2023
 

 

 

Cavendish Financial Plc

Board Changes

 

19 DECEMBER 2023

Cavendish Financial plc announces that Mark Astaire has been appointed to its Board of Directors as an independent Non-Executive Director with effect from 1 January 2024.

Mark brings over 35 years of investment banking experience to the Board having held a number of senior leadership positions including Chairman of Corporate Broking at Barclays and Head of Corporate Broking at Bank of America Merrill Lynch. Mark was also a member of the Takeover Panel.

Mark is a member of the board of Sky News (which protects the editorial independence of Sky News), a Trustee of the charity Breast Cancer Now and a member of the International Advisory Board of the University of Edinburgh Business School.

Robert Lister, Deputy Chairman has informed us of his intention to step down from the Board of Directors on 31 December 2023 having led finnCap Group plc ("finnCap"), as Chairman, through its merger and subsequent integration with Cenkos Securities plc creating Cavendish Financial Plc in September 2023.

Commenting on today's announcement, Lisa Gordon, Chair said:

"I am delighted to welcome Mark to Cavendish and look forward to working with him. His appointment ensures that the Board has substantial and differential investment banking and client service experience as we continue to build on our strategic potential following our merger in September.

Robert - as Chairman - successfully led finnCap through a period of complex strategic and leadership change and was a tremendous partner in the creation of the new combined Group. On behalf of the Board, I would like to thank him for his significant contribution to the Board both pre-merger and during the integration of our businesses, which is now complete."

Commenting on his appointment, Mark Astaire said:

"Cavendish is a unique full-service investment bank focused on the small and mid-market, with the largest AIM client base and strong M&A franchises both in private and public company transactions.

I am very pleased to be joining the Board and look forward to working with Lisa and the wider Board, to deliver on Cavendish's potential."

Further information relating to Mark Astaire as required to be disclosed under the AIM Rules for Companies is set out below.

 

 

 

Contacts

Cavendish (Management) Tel: +44 (0) 20 7220 0500

Lisa Gordon, Chair investor.relations@cavendish.com

Julian Morse, Co-Chief Executive Officer

John Farrugia, Co-Chief Executive Officer

Ben Procter, Chief Financial Officer

 

Grant Thornton (Nominated Adviser) Tel: +44 (0) 20 7383 5100

Philip Secrett/Samantha Harrison/Ciara Donnelly

Cavendish (Broker) Tel: +44 (0) 20 7220 0500

Tim Redfern

Hudson Sandler (PR adviser) Tel: +44 (0) 20 7796 4133

Dan de Belder/Rebekah Chapman

 

The following information is disclosed in accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies in connection with the appointment of Mark David Astaire, aged 64, to the Board of the Company:

Current directorships

The Wendover Foundation (Trustee of the Charity)

Breast Cancer Now (Director and Trustee of the Charity)

The Goodwinds II Trust (Protector)

Past directorships held within the last five years

Breast Cancer Care (Director and Trustee of the Charity)

The Takeover Panel

Mark does not hold any legal or beneficial direct or indirect interest in the securities of the Company.

There are no other matters under paragraph (g) of Schedule 2 of the AIM Rules to be disclosed.

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOANKFBDKBDBNBD
Date   Source Headline
22nd Apr 202410:00 amRNSDirectors Dealings
8th Apr 20247:01 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSChange of Nominated Adviser
4th Apr 20247:00 amRNSTrading Update
28th Mar 20247:00 amRNSTotal Voting Rights
19th Mar 20242:26 pmRNSDirectors Dealings and Total Voting Rights
29th Feb 20247:00 amRNSTotal Voting Rights
20th Feb 20247:00 amRNSTotal Voting Rights and Directors Dealings
19th Feb 20247:00 amRNSLaunch of SIP and Co-investment Plan
19th Jan 20247:00 amRNSHolding(s) in Company
20th Dec 202310:19 amRNSIncoming Director Dealing
19th Dec 202311:11 amRNSDirector Dealings
19th Dec 20237:00 amRNSBoard Changes
19th Dec 20237:00 amRNS2024 Interim Results
1st Dec 20237:00 amRNSBlock Admission Return and Total Voting Rights
29th Sep 202310:44 amRNSResult of AGM
29th Sep 20237:00 amRNSAGM Trading Statement
19th Apr 20056:24 pmRNSOffer Update
12th Apr 20053:13 pmRNSAGM Statement
5th Apr 20057:01 amRNSOffer Update/Directorate
2nd Mar 200510:54 amRNSOffer Update
1st Mar 20051:16 pmRNSOffer Update
21st Feb 20057:00 amRNSOffer Update
31st Jan 20059:26 amRNSOffer Document Posted
28th Jan 20055:47 pmRNSDividend Declaration
28th Jan 20054:34 pmRNSOffer by Chrysalis VCT plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.